top of page

NEWS & BLOGS
Blog: Blog2


FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19
Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain...
Provision Consulting Group
Dec 9, 20214 min read
6


Beware of Vaping Products with Unproven Health Claims
The U.S. Food and Drug Administration wants consumers to know certain “wellness” vaping products containing vitamins and/or essential...
Provision Consulting Group
Dec 7, 20213 min read
9


SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests
The SARS-CoV-2 virus has mutated over time, resulting in genetic variation in the population of circulating viral strains over the course...
Provision Consulting Group
Dec 6, 202111 min read
20


FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention
FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric...
Provision Consulting Group
Dec 6, 20213 min read
4


Pregnant? Breastfeeding? FDA Aims to Improve Drug Information
People who are pregnant or breastfeeding often need to take prescription medications. Prescription-medication use during pregnancy and...
Provision Consulting Group
Dec 2, 20213 min read
3


Prepare for the New ISO 10993-10 : 2021
ISO 10993-10:2021 "Biological evaluation of medical devices - Part 10: Tests for skin sensitization" ISO 10993-10:2021 "Biological...
Provision Consulting Group
Dec 1, 20212 min read
255


Coronavirus (COVID-19) Update
FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters As we have with...
Provision Consulting Group
Nov 30, 20213 min read
5


FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
The U.S. Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying...
Provision Consulting Group
Nov 29, 20212 min read
3


FDA Approves First Treatment for Post- Transplant Infection that is Resistant to Other Drugs
The U.S. Food and Drug Administration approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12...
Provision Consulting Group
Nov 24, 20212 min read
7


FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
The U.S. Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older...
Provision Consulting Group
Nov 22, 20212 min read
11
bottom of page